V Adduru1,2,3, S A Baum3,4, C Zhang2,3, M Helguera3,5, R Zand2, M Lichtenstein2, C J Griessenauer2, A M Michael6,2,3. 1. From the Duke Institute for Brain Sciences (V.A., A.M.M.), Duke University, Durham, North Carolina. 2. Neuroscience Institute (V.A., C.Z., R.Z., M.L., C.J.G., A.M.M.), Geisinger Health System, Danville, Pennsylvania. 3. Chester F. Carlson Center for Imaging Science (V.A., S.A.B., C.Z., M.H., A.M.M.), Rochester Institute of Technology, Rochester, New York. 4. Faculty of Science (S.A.B.), University of Manitoba, Winnipeg, Manitoba, Canada. 5. Instituto Tecnológico José Mario Molina Pasquel y Henríquez (M.H.), Lagos de Moreno, Jalisco, Mexico. 6. From the Duke Institute for Brain Sciences (V.A., A.M.M.), Duke University, Durham, North Carolina andrew.michael@duke.edu.
Abstract
BACKGROUND AND PURPOSE: Total brain volume and total intracranial volume are important measures for assessing whole-brain atrophy in Alzheimer disease, dementia, and other neurodegenerative diseases. Unlike MR imaging, which has a number of well-validated fully-automated methods, only a handful of methods segment CT images. Available methods either use enhanced CT, do not estimate both volumes, or require formal validation. Reliable computation of total brain volume and total intracranial volume from CT is needed because head CTs are more widely used than head MRIs in the clinical setting. We present an automated head CT segmentation method (CTseg) to estimate total brain volume and total intracranial volume. MATERIALS AND METHODS: CTseg adapts a widely used brain MR imaging segmentation method from the Statistical Parametric Mapping toolbox using a CT-based template for initial registration. CTseg was tested and validated using head CT images from a clinical archive. RESULTS: CTseg showed excellent agreement with 20 manually segmented head CTs. The intraclass correlation was 0.97 (P < .001) for total intracranial volume and 0.94 (P < .001) for total brain volume. When CTseg was applied to a cross-sectional Alzheimer disease dataset (58 with Alzheimer disease patients and 58 matched controls), CTseg detected a loss in percentage total brain volume (as a percentage of total intracranial volume) with age (P < .001) as well as a group difference between patients with Alzheimer disease and controls (P < .01). We observed similar results when total brain volume was modeled with total intracranial volume as a confounding variable. CONCLUSIONS: In current clinical practice, brain atrophy is assessed by inaccurate and subjective "eyeballing" of CT images. Manual segmentation of head CT images is prohibitively arduous and time-consuming. CTseg can potentially help clinicians to automatically measure total brain volume and detect and track atrophy in neurodegenerative diseases. In addition, CTseg can be applied to large clinical archives for a variety of research studies.
BACKGROUND AND PURPOSE: Total brain volume and total intracranial volume are important measures for assessing whole-brain atrophy in Alzheimer disease, dementia, and other neurodegenerative diseases. Unlike MR imaging, which has a number of well-validated fully-automated methods, only a handful of methods segment CT images. Available methods either use enhanced CT, do not estimate both volumes, or require formal validation. Reliable computation of total brain volume and total intracranial volume from CT is needed because head CTs are more widely used than head MRIs in the clinical setting. We present an automated head CT segmentation method (CTseg) to estimate total brain volume and total intracranial volume. MATERIALS AND METHODS: CTseg adapts a widely used brain MR imaging segmentation method from the Statistical Parametric Mapping toolbox using a CT-based template for initial registration. CTseg was tested and validated using head CT images from a clinical archive. RESULTS: CTseg showed excellent agreement with 20 manually segmented head CTs. The intraclass correlation was 0.97 (P < .001) for total intracranial volume and 0.94 (P < .001) for total brain volume. When CTseg was applied to a cross-sectional Alzheimer disease dataset (58 with Alzheimer diseasepatients and 58 matched controls), CTseg detected a loss in percentage total brain volume (as a percentage of total intracranial volume) with age (P < .001) as well as a group difference between patients with Alzheimer disease and controls (P < .01). We observed similar results when total brain volume was modeled with total intracranial volume as a confounding variable. CONCLUSIONS: In current clinical practice, brain atrophy is assessed by inaccurate and subjective "eyeballing" of CT images. Manual segmentation of head CT images is prohibitively arduous and time-consuming. CTseg can potentially help clinicians to automatically measure total brain volume and detect and track atrophy in neurodegenerative diseases. In addition, CTseg can be applied to large clinical archives for a variety of research studies.
Authors: Charles D Smith; Himachandra Chebrolu; David R Wekstein; Frederick A Schmitt; William R Markesbery Journal: Neurobiol Aging Date: 2006-06-13 Impact factor: 4.673
Authors: Venkateswararao Cherukuri; Peter Ssenyonga; Benjamin C Warf; Abhaya V Kulkarni; Vishal Monga; Steven J Schiff Journal: IEEE Trans Biomed Eng Date: 2017-12-13 Impact factor: 4.538
Authors: J Mazziotta; A Toga; A Evans; P Fox; J Lancaster; K Zilles; R Woods; T Paus; G Simpson; B Pike; C Holmes; L Collins; P Thompson; D MacDonald; M Iacoboni; T Schormann; K Amunts; N Palomero-Gallagher; S Geyer; L Parsons; K Narr; N Kabani; G Le Goualher; D Boomsma; T Cannon; R Kawashima; B Mazoyer Journal: Philos Trans R Soc Lond B Biol Sci Date: 2001-08-29 Impact factor: 6.237
Authors: Andrei Irimia; Alexander S Maher; Kenneth A Rostowsky; Nahian F Chowdhury; Darryl H Hwang; E Meng Law Journal: Front Neuroinform Date: 2019-03-18 Impact factor: 4.081
Authors: Sven PR Luijten; Kars CJ Compagne; Adriaan CGM van Es; Yvo BWEM Roos; Charles BLM Majoie; Robert J van Oostenbrugge; Wim H van Zwam; Diederik WJ Dippel; Frank J Wolters; Aad van der Lugt; Daniel Bos Journal: Int J Stroke Date: 2021-10-28 Impact factor: 6.948
Authors: Aku L Kaipainen; Johanna Pitkänen; Fanni Haapalinna; Olli Jääskeläinen; Hanna Jokinen; Susanna Melkas; Timo Erkinjuntti; Ritva Vanninen; Anne M Koivisto; Jyrki Lötjönen; Juha Koikkalainen; Sanna-Kaisa Herukka; Valtteri Julkunen Journal: Neuroradiology Date: 2021-08-14 Impact factor: 2.804